Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications

Journal Article · · Nuclear Medicine and Biology

Bismuth-213 is a radionuclide of interest for targeted alpha therapy and is supplied via a radiochemical generator system through the decay of 225Ac. Radionuclide generators employ longer lived “parent” radionuclides to routinely supply shorter-lived “daughter” radionuclides. The traditional 225Ac/213Bi radiochemical generator relies on an organic cation exchange resin where 225Ac binds to the resin and 213Bi is routinely eluted. These resins degrade when they absorb large doses of ionizing radiation (>1 × 106 Gy/mg), which has been observed when the loading activity of 225Ac exceeds 2.59*109 Bq (70 mCi). Herein we report the development of an electrochemical generator for the supply of 213Bi that has the potential to overcome this limitation. Bismuth-213 spontaneously electrodeposits onto nickel foils in 0.1 M hydrochloric acid at 70 °C. Using this method, we were able to plate an average of 73 ± 4 % of the 213Bi in solution and obtain a final 213Bi recovery of 65 ± 8 % in 0.1 M citrate pH 4.5 via reverse electrolysis using titanium as the cathode. The recovered 213Bi had an average radiochemical purity of >99.8 % and was successfully used to radiolabel DOTATATE with an average radiochemical yield of 85.1 % (not optimized).

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Laboratory Directed Research and Development (LDRD) Program
Grant/Contract Number:
89233218CNA000001
OSTI ID:
2433936
Report Number(s):
LA-UR--24-22113
Journal Information:
Nuclear Medicine and Biology, Journal Name: Nuclear Medicine and Biology Vol. 136-137; ISSN 0969-8051
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (18)

213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience journal July 2014
Influence of metal ions on the 44Sc-labeling of DOTATATE journal August 2019
An overview of targeted alpha therapy journal December 2011
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: development of new methods, quantitative characterization, and implications for clinical use journal November 2001
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation journal May 1999
Development of an electrochemical 188W/188Re generator as a technique for separation and purification of 188Re in radiopharmaceutical applications journal December 2016
Various Chromatographic Schemes for Separation of 213Bi from 225Ac journal December 2019
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy journal February 2008
A novel electrochemical technique for the production of clinical grade 99mTc using (n, γ)99Mo journal January 2010
Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions journal May 2012
Metal Oxide Sorbents for the Separation of Radium and Actinium journal November 2020
Electrochemical Separation: Promises, Opportunities, and Challenges To Develop Next-Generation Radionuclide Generators To Meet Clinical Demands journal February 2014
Development of a Unique Bismuth (Bi-213) Automated Generator for Use in Cancer Therapy journal September 2000
Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary journal November 2013
Targeted Alpha Therapy with 213Bi journal October 2011
Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes journal June 2012
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies journal October 2018
A Radionuclide Generator of High-Purity Bi-213 for Instant Labeling journal June 2021

Similar Records

{sup 225}Ac/{sup 213}Bi biomedical generator
Journal Article · Sun Nov 30 23:00:00 EST 1997 · Transactions of the American Nuclear Society · OSTI ID:552686

225Ac/213Bi Generator Based on Millifluidics Controlled Electrodeposition
Technical Report · Tue Aug 31 00:00:00 EDT 2021 · OSTI ID:1822690

Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
Journal Article · Sun Nov 20 23:00:00 EST 2016 · EJNMMI Research · OSTI ID:1627030